Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of ABL1 (phospho Y134) polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | Dot-Pep,IHC-P |
More info about ABL1 (phospho Y134) polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB0396 |
| Product name: | ABL1 (phospho Y134) polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic phosphopeptide of ABL1. |
| Gene id: | 25 |
| Gene name: | ABL1 |
| Gene alias: | ABL|JTK7|bcr/abl|c-ABL|p150|v-abl |
| Gene description: | c-abl oncogene 1, receptor tyrosine kinase |
| Immunogen: | Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding Y134 of human ABL1. |
| Protein accession: | NP_005148;P00519 |
| Form: | Liquid |
| Recommend dilutions: | Immunohistochemistry (1:50-100) Dot Blot (1:500) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Dot blot analysis of ABL1 (phospho Y134) polyclonal antibody (Cat # PAB0396) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. |
| Applications: | Dot-Pep,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.Aichberger KJ, Mayerhofer M, Krauth MT, Skvara H, Florian S, Sonneck K, Akgul C, Derdak S, Pickl WF, Wacheck V, Selzer E, Monia BP, Moriggl R, Valent P, Sillaber C. Blood. 2005 Apr 15;105(8):3303-11. Epub 2004 Dec 30. |